How the FDA stood up to the President

New York Times

20 October 2020 - Dr. Stephen Hahn, the F.D.A. commissioner, occupies a fraught position, caught between pressure from the White House and distraught agency scientists who wonder if Dr. Hahn can protect their work.

On 23 September Dr. Stephen M. Hahn left a virtual meeting of the White House’s coronavirus task force to take a call from the president’s chief of staff, Mark Meadows.

Mr. Meadows was angry with Dr. Hahn, the head of the FDA, for pushing new guidelines for vaccine developers, according to two senior administration officials familiar with the call who requested anonymity because they were not authorised to discuss it.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder